www.fdanews.com/articles/189685-amra-receives-fda-ok-for-magnetic-resonance-diagnostic-software
AMRA Receives FDA OK for Magnetic Resonance Diagnostic Software
December 27, 2018
The FDA cleared AMRA Medical’s AMRA Profiler, a non-invasive magnetic resonance diagnostic device that measures body composition, for marketing in the U.S.
The profiler uses images from a six-minute whole body MRI scan to generate 3D-volumetric fat and muscle measurements.
The software application enables an accurate assessment of a patient’s metabolic status.